Lacuzong product liability case against GlaxoSmithKline (makers of Paxil®)
The suit Lacuzong v. GlaxoSmithKline (GSK) was brought by the widow of a man who drowned their two children and himself in a tub after taking Paxil for three days. The case was “resolved” to the satisfaction of the family; the drug company denied and continues to deny all of the allegations of negligence in developing and marketing Paxil.
At GSK’s insistence, Dr. Breggin’s report remained sealed. However, in a more recent case against the company, Moffett v. GlaxoSmithKline* (in which, notably, Dr. Breggin was also an expert), the United States District Court for the South District of Mississippi made the report available; it is linked below.
- Paxil suicide product liability case “resolved”
- Suppressed Paxil suicide data released: expert calls for drug companies to publish safety and efficacy data
- Paxil Withdrawal Case, California. Attorney Don Farber and Expert P. Breggin.
- Copy of Dr. Breggin’s Paxil Product Liability Report in the Lacuzong Case. (PDF)
- Court filing makes public my previously suppressed analysis of Paxil’s effects (PDF)
- Drug Company Suppressed Data on Paroxetine-Induced Stimulation (PDF)
- How GlaxoSmithKline suppressed data on Paxil-induced akathisia (PDF)